Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
265
datasets available to search
ShareScore release 0.9.0
Dataset results
265 results for “Aromatase inhibitors”
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT00688194. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)
ClinicalTrials.gov study NCT04568616. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
ClinicalTrials.gov study NCT06830720. IPD Sharing: Not stated. Countries: 2. Publications: 0.
The Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.
ClinicalTrials.gov study NCT02057536. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetic Predictors to Acupuncture Response for Arthralgia Induced by Aromatase Inhibitors in Patients With Breast Cancer
ClinicalTrials.gov study NCT05125432. IPD Sharing: NO. Countries: 1. Publications: 0.
Preventing Sexual Dysfunction With Aromatase Inhibitors
ClinicalTrials.gov study NCT01603303. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insur
ClinicalTrials.gov study NCT05132101. IPD Sharing: NO. Countries: 1. Publications: 0.
Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer
ClinicalTrials.gov study NCT04941885. IPD Sharing: NO. Countries: 1. Publications: 0.
Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT00784888. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
ClinicalTrials.gov study NCT02738866. IPD Sharing: NO. Countries: 1. Publications: 0.
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT02760030. IPD Sharing: NO. Countries: 1. Publications: 0.
Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients
ClinicalTrials.gov study NCT01983995. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase Inhibitors
ClinicalTrials.gov study NCT01431872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Activity Program During Aromatase Inhibitor Therapy
ClinicalTrials.gov study NCT03786198. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms
ClinicalTrials.gov study NCT02118636. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors
ClinicalTrials.gov study NCT03707340. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast Cancer
ClinicalTrials.gov study NCT06610565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Targeted Physiotherapeutic Treatment for Aromatase Inhibitor-associated Musculoskeletal Pain in Breast Cancer Survivors
ClinicalTrials.gov study NCT04560699. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer
ClinicalTrials.gov study NCT01080170. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who
ClinicalTrials.gov study NCT02730091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.